Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
EntreMed Issued U.S. Patent For Active Parts Of Endostatin.
This article is from
The Cancer Letter
archive.
Vol. 27 No. 09 | March 2, 2001
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Coalition Agrees On Method To Coordinate Issues
March 21, 1980
TCL Archive
New Protocol Could Improve Survival Of Rare Brain Tumor
October 30, 2009
TCL Archive
ODAC Okays Photofrin for Obstructive Esophageal Cancer
September 23, 1994
TCL Archive
Urologists support Approval Of Il-2 for Kidney Cancer
February 1, 1991
TCL Archive
More Bad News for AVEO As Tivozanib Partner Bids Adieu
May 31, 2013
TCL Archive
Abstracts From AACR Annual Meeting
June 4, 1976
